Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...
Two genetic variants may help explain differences in side effects and weight loss in patients taking GLP-1 drugs.
Serially cloned mice hit a genetic “dead end” by generation 58, underscoring that sex evolved for variation, purging harmful ...
New findings could partially help explain why some people appear to lose weight more quickly than others while taking the ...
Me turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total ...
A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...
Type 1 diabetes is an autoimmune condition in which the body attacks its own insulin-producing cells in the pancreas. Some ...
Distinct GLP1R and GIPR variants correlated with nausea/vomiting risk, with a GIPR signal appearing tirzepatide-specific and showing markedly increased vomiting odds. New studies from 23andMe suggest ...
Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...
Researchers still do not have a comprehensive picture of the factors that influence gene expression in human cancers. Understanding gene expression in cancer is important because it can reveal how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results